collection
MENU ▼
Read by QxMD icon Read
search

Lupus

shared collection
15 papers 0 to 25 followers
By Fatih Kelesoglu ...
https://www.readbyqxmd.com/read/26729463/systemic-lupus-erythematosus-in-2015-cellular-and-metabolic-requirements-of-effector-t-cells
#1
George C Tsokos
No abstract text is available yet for this article.
February 2016: Nature Reviews. Rheumatology
https://www.readbyqxmd.com/read/27060062/association-between-functional-nlrp3-polymorphisms-and-susceptibility-to-autoimmune-and-inflammatory-diseases-a-meta-analysis
#2
Y H Lee, S-C Bae
OBJECTIVE: This study determined whether NLRP3 polymorphisms rs35829419 C/A and rs10754558 C/G were associated with autoimmune and inflammatory diseases. METHODS: An association between the NLRP3 rs35829419 C/A and rs10754558 C/G polymorphisms and autoimmune and inflammatory diseases was determined by performing a meta-analysis by using (1) allele contrast, (2) recessive, (3) dominant, and (4) co-dominant models. RESULTS: Thirty comparative studies involving 8069 patients and 8824 controls were included in the meta-analysis...
April 7, 2016: Lupus
https://www.readbyqxmd.com/read/26848232/stevens-johnson-syndrome-like-skin-lesions-in-a-patient-with-juvenile-systemic-lupus-erythematosus
#3
Hee Won Jang, Jung Jin Shin, Jae Beom Park, Sang Wook Son
No abstract text is available yet for this article.
February 2016: Annals of Dermatology
https://www.readbyqxmd.com/read/26845404/oxidation-and-mitochondrial-origin-of-net-dna-in-the-pathogenesis-of-lupus
#4
COMMENT
Sylviane Muller, Marko Radic
No abstract text is available yet for this article.
February 2016: Nature Medicine
https://www.readbyqxmd.com/read/26846693/serological-profile-and-clinical-features-of-nucleolar-antinuclear-pattern-in-patients-with-systemic-lupus-erythematosus-from-southwestern-spain
#5
C M Cabrera, E Fernández-Grande, J M Urra
Nucleolar staining of antinuclear antibodies (ANAs) is not exclusive to patients suffering systemic sclerosis (SSc) since it can occur in other autoimmune diseases, such as systemic lupus erythematosus (SLE). The nucleolar ANA pattern presents a low incidence in patients with SLE, with less than 9% reported in some studies. The significance of nucleolar staining and antinucleolar antibodies (ANoA) in SLE is still unknown, as is its association with clinical manifestations. To address these issues, a case-control study was carried out...
August 2016: Lupus
https://www.readbyqxmd.com/read/26851551/a-link-allergic-rhinitis-asthma-systemic-lupus-erythematosus
#6
REVIEW
Eric Sin, Prachi Anand, Marianne Frieri
This review has discussed a link between allergic rhinitis, asthma and systemic lupus erythematosus (SLE) and a case report in this area. A clear link with symptoms of allergic rhinitis, asthma and SLE exists. Several articles found on pubmed in the literature are listed on allergic rhinitis and allergy, Th1-immune responses, mast cells in autoimmunity, total immunoglobulin E levels in lupus, atopic diseases and SLE are reviewed. In addition, risks and correlations, genetic predisposition, environmental factors, immune regulation, elevated serum IgE levels, regulatory B cells for both allergic and autoimmune diseases are mentioned, Asthma and the vascular endothelial cell growth factor, asthma and autoimmune diseases, allergy and autoimmunity, neutrophils, innate and adaptive immunity in the development of SLE, the (Tim) gene family, complement activation in SLE and immunomodulation, hypersensitivity reactions in autoimmunity are discussed...
May 2016: Autoimmunity Reviews
https://www.readbyqxmd.com/read/26804757/secreted-autoantibody-repertoires-in-sj%C3%A3-gren-s-syndrome-and-systemic-lupus-erythematosus-a-proteomic-approach
#7
REVIEW
Mahmood A Al Kindi, Alex D Colella, Tim K Chataway, Michael W Jackson, Jing J Wang, Tom P Gordon
The structures of epitopes bound by autoantibodies against RNA-protein complexes have been well-defined over several decades, but little is known of the clonality, immunoglobulin (Ig) variable (V) gene usage and mutational status of the autoantibodies themselves at the level of the secreted (serum) proteome. A novel proteomic workflow is presented based on affinity purification of specific Igs from serum, high-resolution two-dimensional gel electrophoresis, and de novo and database-driven sequencing of V-region proteins by mass spectrometry...
April 2016: Autoimmunity Reviews
https://www.readbyqxmd.com/read/26809011/treat-to-target-in-systemic-lupus-erythematosus-are-we-there-yet
#8
Chi Chiu Mok
The treat-to-target (T2T) strategy has proven benefits in several chronic medical illnesses including rheumatoid arthritis. Whether the T2T principle can be applied to SLE has become a recent topic of discussion. A European panel of rheumatologists agrees that treatment of SLE should target at multiple goals that include control of disease activity, prevention of disease flares, minimization of disease or treatment related comorbidity, and improvement of quality of life. Therapy of SLE should aim at remission or when remission cannot be achieved, the lowest possible disease activity that is assessed by a validated lupus activity index and/or organ-specific markers...
2016: Expert Review of Clinical Pharmacology
https://www.readbyqxmd.com/read/26812129/antinuclear-antibody-negative-lupus-nephritis-with-full-house-nephropathy-a-case-report-and-review-of-the-literature
#9
Sierra C Simmons, Maxwell L Smith, April Chang-Miller, Mira T Keddis
Lupus nephritis (LN) is a serious and common complication of systemic lupus erythematosus (SLE) that predisposes to significant morbidity and mortality. Studies show that prompt diagnosis and treatment improves patient survival. We present a case of a 49-year-old female with an atypical presentation of LN who initially presented with new-onset hypertension, edema, arthritis, serositis and recently diagnosed leukocytoclastic vasculitis who later developed acute kidney injury, hematuria and nephrotic syndrome...
2015: American Journal of Nephrology
https://www.readbyqxmd.com/read/26819561/clinical-features-of-neuropsychiatric-syndromes-in-systemic-lupus-erythematosus-and-other-connective-tissue-diseases
#10
REVIEW
Tsuyoshi Kasama, Airi Maeoka, Nao Oguro
Systemic lupus erythematosus (SLE) and related disorders are chronic inflammatory diseases characterized by abnormalities and, in some cases, even complete failure of immune responses as the underlying pathology. Although almost all connective tissue diseases and related disorders can be complicated by various neuropsychiatric syndromes, SLE is a typical connective tissue disease that can cause neurological and psychiatric syndromes. In this review, neuropsychiatric syndromes complicating connective tissue diseases, especially SLE are outlined, and pathological and other conditions that should be considered in the differential diagnosis are also discussed...
2016: Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders
https://www.readbyqxmd.com/read/26809245/management-of-neuropsychiatric-systemic-lupus-erythematosus-current-approaches-and-future-perspectives
#11
REVIEW
César Magro-Checa, Elisabeth J Zirkzee, Tom W Huizinga, Gerda M Steup-Beekman
Neuropsychiatric systemic lupus erythematosus (NPSLE) is a generic definition referring to a series of neurological and psychiatric symptoms directly related to systemic lupus erythematosus (SLE). NPSLE includes heterogeneous and rare neuropsychiatric (NP) manifestations involving both the central and peripheral nervous system. Due to the lack of a gold standard, the attribution of NP symptoms to SLE represents a clinical challenge that obligates the strict exclusion of any other potential cause. In the acute setting, management of these patients does not differ from other non-SLE subjects presenting with the same NP manifestation...
March 2016: Drugs
https://www.readbyqxmd.com/read/26729459/towards-new-avenues-in-the-management-of-lupus-glomerulonephritis
#12
REVIEW
C C Mok
Renal involvement in systemic lupus erythematosus (SLE) carries substantial morbidity and mortality. Conventional immunosuppressive agents (cyclophosphamide and azathioprine) have suboptimal efficacy and substantial toxicity. Mycophenolate mofetil has emerged as an alternative agent for both induction and maintenance therapy in lupus nephritis because of its reduced gonadal toxicity, despite its failure to demonstrate superiority over cyclophosphamide in pivotal studies. The calcineurin inhibitor tacrolimus has equivalent efficacy to cyclophosphamide and mycophenolate mofetil for inducing remission of lupus nephritis...
April 2016: Nature Reviews. Rheumatology
https://www.readbyqxmd.com/read/26170222/predictors-of-arthritis-in-pediatric-patients-with-lupus
#13
S D Sule, D G Moodalbail, J Burnham, B Fivush, S L Furth
BACKGROUND: Arthritis is one of the most common manifestations of systemic lupus erythematosus (SLE). Although typically non-erosive and non-deforming, children with SLE arthritis can have significant morbidity with decreased quality of life. Our goal was to identify potential clinical and laboratory predictors of arthritis in a cohort of pediatric patients with SLE. METHODS: We performed a cohort study of incident and prevalent patients with SLE aged ≤ 19 years...
2015: Pediatric Rheumatology Online Journal
https://www.readbyqxmd.com/read/19587374/how-i-treat-the-antiphospholipid-syndrome
#14
REVIEW
Bill Giannakopoulos, Steven A Krilis
This article discusses how we approach medical decision making in the treatment of the various facets of the antiphospholipid syndrome (APS), including secondary prophylaxis in the setting of venous and arterial thrombosis, as well as treatment for the prevention of recurrent miscarriages and fetal death. The role of primary thromboprophylaxis is also discussed in depth. Great emphasis is given to incorporating the most up-to-date and relevant evidence base both from the APS literature, and from large, recent, randomized controlled trials (RCTs) of primary and secondary thrombotic prophylaxis in the general population setting (ie, the population that has not been specifically investigated for APS)...
September 3, 2009: Blood
https://www.readbyqxmd.com/read/26615611/chronic-arthritis-in-systemic-lupus-erythematosus-distinct-features-in-336-paediatric-and-1830-adult-patients
#15
COMPARATIVE STUDY
Natali W S Gormezano, Clovis A Silva, Nadia E Aikawa, Diego L Barros, Mariana A da Silva, Carini I Otsuzi, Katia Kozu, Luciana Parente Seguro, Rosa M R Pereira, Eloisa Bonfá
The objectives of this study are to assess the frequency of chronic arthritis and compare the clinical and laboratory features in a large population of childhood-onset systemic lupus erythematosus (cSLE) and adult-onset (aSLE) patients. This historical study evaluated 336 cSLE and 1830 aSLE patients. Chronic arthritis was defined as synovitis of at least 6 weeks of duration. Rhupus was characterised as the association of SLE and chronic inflammatory arthritis with erosion and positive rheumatoid factor. Jaccoud's arthropathy is a non-erosive subluxation leading to severe deformity of the hands and feet...
January 2016: Clinical Rheumatology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"